Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation
Authors:
Open Access
- 3 December 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 17 (3) , 251-260
Abstract
Depression is a common problem among patients awaiting organ transplantation, but little is known about the impact of depression and its treatment on the outcomes of liver transplantation. In this retrospective cohort analysis, we studied all patients over 18 years of age who underwent liver transplantation during a 5-year period (2004-2008) at a single center. Among 179 recipients, 65 patients had depression, as defined by a health care provider assessment, before transplantation. Depression was defined as past or active depression or an adjustment disorder. The associations between pretransplant depression and various outcomes (time to death, graft failure, first acute cellular rejection episode, first infection, and first rehospitalization) were assessed. In the entire sample, more patients with depression required posttransplant psychiatric care (37% versus 18%); the adjusted hazard ratio was 2.28 (1.27-4.11). The rates of other outcomes, including hospital readmission, acute cellular rejection, graft failure, mortality, and infection, were similar for patients with depression and patients without depression. Among those with depression, patients on antidepressants at the time of transplantation had acute cellular rejection less frequently than those not taking antidepressants (13% versus 40%); the adjusted hazard ratio was 0.14 (0.03-0.62). The rates of other outcomes were similar between these 2 groups. These data indicate that depression affects posttransplant psychiatric morbidity but not other medical outcomes of liver transplantation. Pharmacological treatment of depression may significantly reduce the incidence of acute cellular rejection in patients undergoing liver transplantation. However, future prospective studies of mental health and liver transplantation are required to definitively assess the effects of antidepressant medications on medical outcomes. Liver Transpl, 2011. © 2011 AASLD.Keywords
This publication has 19 references indexed in Scilit:
- Glucocorticoids, cytokines and brain abnormalities in depressionProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug AdministrationBMJ, 2009
- Psychiatric Care of Patients Undergoing Organ TransplantationTransplantation, 2009
- Pretransplant Predictors of Posttransplant Adherence and Clinical OutcomeTransplantation, 2009
- Psychiatric Evaluations of Heart Transplant Candidates: Predicting Post-Transplant Hospitalizations, Rejection Episodes, and SurvivalPsychosomatics, 2006
- Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk IndexAmerican Journal of Transplantation, 2006
- PREDICTORS OF RELAPSE TO HARMFUL ALCOHOL AFTER ORTHOTOPIC LIVER TRANSPLANTATIONAlcohol and Alcoholism, 2006
- Association of Depressive Syndrome and Early Deaths Among Patients After Stem-Cell Transplantation for Malignant DiseasesJournal of Clinical Oncology, 2002
- Depression in patients being evaluated for heart transplantationGeneral Hospital Psychiatry, 1989
- Psychiatric morbidity in patients with alcoholic liver disease.BMJ, 1983